- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Natco Pharma Ltd. (NATP)
786.60
-7.95(-1.00%)
Real-time Data·
Fair Value
An estimate of a Natco Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
779.05
791.75
52 wk Range
773.60
1,226.80
NATP Technical Analysis
A summary for the Natco Pharma Ltd. share. Signals range from Strong Buy, Buy, Neutral, Sell to Strong Sell. It also offers detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and Buy, Sell, Overbought, Oversold or Neutral signals of common chart indicators (including RSI, MACD and CCI). Additionally, the page contains pivot points for Standard, Fibonacci and Camarilla, amongst others. All NATP share technical studies are available in select time frames.
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Moving Averages
Strong Sell
Summary:Strong Sell
| Moving Averages: | Strong Sell | Buy: (0) | Sell: (12) |
| Technical Indicators: | Sell | Buy: (2) | Sell: (5) |
Technical Indicators
Summary: SellBuy: 2Neutral: 2Sell: 5
Oct 28, 2026 07:00 GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 48.120 | Neutral | ||
| STOCH(9,6) | 19.556 | Oversold | ||
| STOCHRSI(14) | 20.070 | Oversold | ||
| MACD(12,26) | -0.154 | Sell | ||
| ADX(14) | 9.323 | Neutral | ||
| Williams %R | -65.867 | Sell | ||
| CCI(14) | -87.7589 | Sell | ||
| ATR(14) | 6.3633 | High Volatility | ||
| Highs/Lows(14) | -2.9750 | Sell | ||
| Ultimate Oscillator | 52.531 | Buy | ||
| ROC | 0.159 | Buy | ||
| Bull/Bear Power(13) | -6.5899 | Sell | ||
Moving Averages
Summary: Strong SellBuy: 0Sell: 12
Oct 28, 2026 07:00 GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 787.27 Sell | | 786.50 Sell | | |
| MA10 | 789.40 Sell | | 787.82 Sell | | |
| MA20 | 789.17 Sell | | 788.22 Sell | | |
| MA50 | 787.79 Sell | | 788.93 Sell | | |
| MA100 | 791.23 Sell | | 794.22 Sell | | |
| MA200 | 807.77 Sell | | 808.84 Sell | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 775.40 | 777.70 | 781.15 | 783.45 | 786.90 | 789.20 | 792.65 |
| Fibonacci | 777.70 | 779.90 | 781.25 | 783.45 | 785.65 | 787.00 | 789.20 |
| Camarilla | 783.02 | 783.55 | 784.07 | 783.45 | 785.13 | 785.65 | 786.18 |
| Woodie's | 775.97 | 777.99 | 781.72 | 783.74 | 787.47 | 789.49 | 793.22 |
| DeMark's | - | - | 782.30 | 784.03 | 788.05 | - | - |
FAQ
From a Technical Analysis Perspective, Is Natco Pharma a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Do the Moving Averages for NATCOPHARM Currently Stand?
The moving averages for Natco Pharma show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 0 Buy signals and 12 Sell signals.
What Is the Current Status of the Technical Indicators for Natco Pharma?
The technical indicators for Natco Pharma are in a Strong Sell position based on daily analysis, with 1 signals on buy indicators and 7 sell signals.
What Is NATCOPHARM's 14-Day RSI?
The current Relative Strength Index (RSI) of NATCOPHARM over the 14-day period is 48.120, which suggests that the stock is a Neutral.
What Is NATCOPHARM's MACD?
NATCOPHARM's MACD is -0.154, which suggests that the stock is a Sell.
What Is NATCOPHARM's 5-Day Moving Average?
NATCOPHARM's 5-day moving average is 787.27, suggesting that the stock is a Sell.
What Is NATCOPHARM's 50-Day Moving Average?
NATCOPHARM's 50-day moving average is 787.79, suggesting that the stock is a Sell.
What Is NATCOPHARM's 200-Day Moving Average?
NATCOPHARM's 200-day moving average is 807.77, suggesting that the stock is a Sell.
What Is the Fibonacci Pivot Point Performance Value for NATCOPHARM?
The Fibonacci pivot point performance value for NATCOPHARM is 783.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.